Moxonidine 0.3
MOXIDIP 0.3 is a highly effective antihypertensive medication designed to provide optimal blood pressure control with minimal side effects. It contains Moxonidine 0.3 mg as its active ingredient—a centrally acting agent that specifically targets the imidazoline receptors in the brainstem to regulate blood pressure. This modern approach ensures enhanced efficacy and better tolerability compared to older medications.
The primary benefit of MOXIDIP 0.3 lies in its ability to lower high blood pressure while preserving essential cardiovascular reflexes, offering a gentle yet powerful solution for patients suffering from essential hypertension.
Key Features and Ingredients
Active Ingredient: Moxonidine 0.3 mg
Class: Centrally acting antihypertensive (imidazoline receptor agonist)
Form: Oral tablet
Target Action: Acts on imidazoline receptors in the central nervous system to reduce sympathetic nervous activity, leading to decreased blood pressure
Minimal side effects compared to traditional alpha-2 agonists
Usage
MOXIDIP 0.3 is generally prescribed for the treatment of mild to moderate essential hypertension. It is typically taken once daily, either with or without food, as directed by a healthcare professional. Patients are advised to follow the dosage guidelines strictly to ensure the best outcomes and avoid any potential side effects.
Recommended Dosage: 0.2 mg to 0.4 mg per day (adjusted based on patient response)
Mode of Administration: Oral
Always consult a physician before initiating or changing dosage.
Benefits
Effective Blood Pressure Control: Quickly reduces high blood pressure levels with long-lasting effects
Selective Action: Targets imidazoline receptors more selectively, leading to fewer side effects like dry mouth or sedation
Improved Tolerability: Better tolerated than older central agents such as clonidine
Supports Cardiovascular Health: Reduces strain on the heart and lowers the risk of stroke, heart attack, and kidney damage
Safe for Long-term Use: Proven safety profile with extended use under medical supervision
Conclusion
MOXIDIP 0.3 offers a modern, efficient, and safer alternative for the treatment of essential hypertension. With its active component Moxonidine 0.3 mg, it stands out as a preferred choice for patients seeking reliable blood pressure control without compromising quality of life. Its unique mechanism of action, minimal side effects, and high efficacy make MOXIDIP 0.3 a trusted ally in the journey towards better heart health. Steris Healthcare Pvt Ltd, known as Sterispharma, was founded in February 2018 by a team of experienced professionals in the pharmaceutical industry. Headquartered in Navi Mumbai, the company holds certifications from WHO, GMP, and ISO, reflecting its dedication to maintaining high standards of quality and safety. Sterispharma’s mission is to provide affordable, high-quality medications across India, strictly adhering to WHO guidelines. With the convenience of an online pharmacy, customers can easily order medicines with home delivery options. The company offers a wide range of healthcare products, catering to various medical needs, from rare disease treatments to essential healthcare products. Sterispharma's product range includes solutions for Cardiology, Asthma, Respiratory Issues, Nasal Conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/Antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental Care, and Dermatology. Medicines can be conveniently ordered via Our websites—Sterisonline, Sterisindia, and Sterispharma.
For further information
Email: info@sterispharma.com / contact@sterispharma.com
Call/WhatsApp: 8209542042 , 8824175417
